David McIntyre

David McIntyre

Finanzdirektor/CFO bei BRAEBURN INC.

Vermögen: 153 116 $ am 31.10.2026

55 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

David John McIntyre currently works at Starpharma Holdings Ltd., as Deputy Chairman from 2026, Vytronus, Inc., as Director from 2014, Tendyne Holdings, Inc., as Director, Braeburn, Inc., as Treasurer, Chief Financial Officer, Director & EVP from 2016, Petalion Therapeutics Ltd., as Director, Fisher House Foundation, Inc., as Trustee from 2010, The Law Society of New South Wales, as Member, and Inhibikase Therapeutics, Inc., as Chief Financial Officer from 2025.
Mr. McIntyre also formerly worked at Avedro, Inc., as Director, Gala Therapeutics, Inc., as Director, Tusker Medical, Inc., as Director, Redflex Holdings Pty Ltd., as Independent Non-Executive Director, ROX Medical, Inc., as Non-Executive Director, Heartware Pty Ltd., as CFO, Secretary & Chief Business Officer, Baker & McKenzie LLP (Illinois), as Senior Attorney, KPMG Legal, as Senior Attorney in 2003, AVITA Medical Pty Ltd., as Chief Financial Officer from 2019 to 2020, HeartWare International, Inc., as Chief Operating & Financial Officer & Executive VP in 2011, Tessa Therapeutics Ltd, as Chief Financial Officer from 2020 to 2021, Anthos Therapeutics, Inc., as Chief Financial Officer from 2021 to 2024, AVITA Medical, Inc., as Chief Financial Officer, and Apple Tree Venture Management Llc, as Partner from 2012 to 2020.
Mr. McIntyre received his undergraduate degree from The University of Sydney, graduate degree from the University of Technology Sydney, and Masters Business Admin degree from The Fuqua School of Business.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
30.06.2025 433.299 ( 0,09 % ) 137 174 $ 31.10.2026
15.04.2026 10.285 ( 0,01 % ) 15 942 $ 31.10.2026

Aktive Positionen von David McIntyre

UnternehmenPositionBeginn
BRAEBURN INC. Finanzdirektor/CFO 01.10.2016
INHIBIKASE THERAPEUTICS, INC. Finanzdirektor/CFO 14.04.2025
STARPHARMA HOLDINGS LIMITED Direktor/Vorstandsmitglied 01.03.2020
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 30.10.2014
Direktor/Vorstandsmitglied -
The Law Society of New South Wales
Corporate Officer/Principal -

Ehemalige bekannte Positionen von David McIntyre

UnternehmenPositionEnde
Finanzdirektor/CFO 01.10.2024
Finanzdirektor/CFO 01.10.2021
░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von David McIntyre im Detail an

Ausbildung von David McIntyre

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

61

Beziehungen ersten Grades

24

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen24

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Finance

Commercial Services

The Law Society of New South Wales

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insider
  3. David McIntyre